Anirban Maitra: Better prognosis in pancreatic cancer with lung-only vs. liver metastases
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:
“New Nature Cancer paper from Rosie Sears, Lisa Coussens and colleagues address the clinical question of why patients with Pancreatic Cancer associated with lung-only metastatic disease have a better prognosis than liver metastases.
The answer lies in the ability to tolerate replication stress and the limited T cell immune response that accompanies such tolerance.”
Dr. Anirban Maitra serves as a Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center.
He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
More posts featuring Anirban Maitra.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023